Monte Rosa Therapeutics Announces Positive Interim Phase 1 Data of MRT-8102 Demonstrating Profound CRP Reductions in Elevated CVD-risk Subjects

In subjects with elevated cardiovascular disease (CVD) risk, MRT-8102, a NEK7-directed molecular glue degrader in development for the treatment of NLRP3/IL-1/IL-6 driven inflammatory diseases, ...
Medical Dialogues

High-Sensitivity CRP Identified as a Powerful Prognostic Marker in Heart Failure with Reduced Ejection Fraction: AHJ, December 2025

According to a recent study, in heart failure with reduced ejection fraction (HFrEF) patients, elevated high-sensitivity ...

C-reactive protein outranks ‘bad’ cholesterol as leading heart disease risk marker

C-reactive protein is created by the liver in response to infections, tissue damage, chronic inflammatory states from ...
Medical Xpress

How C-reactive protein outpaced 'bad' cholesterol as leading heart disease risk marker

Heart disease is the leading cause of death in the United States. Since researchers first established the link between diet, cholesterol and heart disease in the 1950s, risk for heart disease has been ...
Times Argus

How C-reactive protein outpaced ‘bad’ cholesterol as leading heart disease risk marker

(The Conversation is an independent and nonprofit source of news, analysis and commentary from academic experts.) Mary J. Scourboutakos, Macon & Joan Brock Virginia Health Sciences at Old Dominion ...